Results 171 to 180 of about 37,373 (211)

DENV outbreak in Italy: the impact on the National Transfusion Network.

Blood transfusion = Trasfusione del sangue
Pati, Ilaria, Pisani, Giulio, Riccardo, Flavia, Venturi, Giulietta, De Angelis, Vincenzo   +4 more
openaire   +2 more sources

Spatiotemporal co-circulation of four dengue serotypes across Mexico, 2020-2025: A space-time scan analysis. [PDF]

PLoS One
Mendoza-Cano O, Trujillo X, Ríos-Silva M, Bricio-Barrios JA, Lugo-Radillo A, Tapia-Vargas R, Venegas-Ramírez J, Ríos-Bracamontes EF, Cuevas-Arellano HB, Cárdenas Y, Aquino-Santos R, Jiménez-Vieyra IA, Uribe-Ramos JM, Benites-Godínez V, Martínez-Díaz TE, López-Rojas M, García-Solórzano A, Murillo-Zamora E.   +17 more
europepmc   +1 more source

Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection. [PDF]

J Virol
Madrigal G, Gebo C, McElvany BD, Symeonides M, Diehl SA, Waickman AT.   +5 more
europepmc   +1 more source

Potent Cross-Serotype Dengue Neutralization with Low ADE by AG-Strand-Targeting Anti-EDIII Antibodies. [PDF]

ACS Omega
Nilchan N, Phungsom A, Tantiwatcharakunthon M, Luangaram P, Pakchotanon P, Duangchinda T, Kraivong R, Prommool T, Srisawat C, Puttikhunt C.   +9 more
europepmc   +1 more source

Evaluating the Suitability of Dengue Viraemia as a Surrogate Efficacy Outcome for Phase III Trials of Dengue Antivirals: A Systematic Review

Gonsalves J, Win YN, Harriss E, Maude R, Chan XH.   +4 more
europepmc   +1 more source

Genomic characterization of dengue circulation in Togo, 2024

Maman I, Halatoko A, Mavian C, Moir M, Wilkinson E, Singh L, Dor G, Poongavanan J, Ramphal Y, Kouma E, Nikiema C, Napo A, Sanko T, Baye B, Chabuka L, Ramakutoane T, Wentzel V, Zakwe N, Baxter C, De Oliveira T, Tegally H, Tshiabuila D, De Villiers S, Liedeman K, Lessells R, Salah FA, Assih M, Tettekpoe MH, Gnama TG, Issa Z, Sylla Y, Koffi AM, Ahadji-Dabla KM, Tchacondo T.   +33 more
europepmc   +1 more source

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes

Virology, 2012
The envelope (E) protein is composed of three domains (ED1, ED2 and ED3) with ED3 targeted by the most potent neutralizing antibodies. DENV-2 strains can be divided into six genotypes. Comparison of ED3 of representative strains of the six genotypes revealed that there are nine variable residues that are specific to a given genotype.
David W C Beasley, Alan Barrett, Gregory D Gromowski   +2 more
exaly   +3 more sources